Gwenn Hansen sold $100K of Nurix Therapeutics, Inc. (NRIX) stock

Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX), sold 4,111 shares of NRIX stock worth $100K, per an SEC Form 4 filed Aug 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 4, 2026, 1 day before it was made public.

NRIX has moved +2.9% since the trade date, from $24.69 to $25.41 (Sep 21, 2026 close).